<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00626366</url>
  </required_header>
  <id_info>
    <org_study_id>498-07-FB</org_study_id>
    <nct_id>NCT00626366</nct_id>
  </id_info>
  <brief_title>Distribution of Topical Nasal Medication Within the Nasal Cavity and Sinuses by Radiographic Comparison</brief_title>
  <official_title>Distribution of Topical Nasal Medication Within the Nasal Cavity and Sinuses by Radiographic Comparison</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nebraska</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nebraska</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the distribution of nasal sprays and nasal drops.
      We hypothesize that nasal drops will reach the frontonasal region more often than nasal
      sprays.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2008</start_date>
  <completion_date type="Anticipated">June 2008</completion_date>
  <primary_completion_date type="Anticipated">April 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To determine the distribution of nasal sprays and drops.</measure>
    <time_frame>2 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">8</enrollment>
  <condition>Chronic Sinusitis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm of the study will contain subjects who will spray 2-4 sprays of a nasal contrast solution in their nares. Following administration of the spray, the subjects will then have a Xoran mini-CAT scan of their sinuses.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm will contain subjects who will place two drops of a nasal contrast solution in each nose. Following administration of the nasal contrast, the subjects will then have a Xoran miniCAT scan of their sinuses.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Sinus CT Scan</intervention_name>
    <description>Subjects will undergo a Xoran miniCAT scan of their sinuses</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Omnipaque 240 Contrast Solution</intervention_name>
    <description>Subjects will spray 2-4 drops of half-strength Omnipaque 240 mgI/mL into each nare. Each spray is approximately 0.1 ml.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Omnipaque 240 mg I/mL</intervention_name>
    <description>Subjects will place two drops of half-strength Omnipaque 240 mg I/mL intranasally to each nose. Each drop is approximately 1 ml.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult able to perform activities of daily living

        Exclusion Criteria:

          -  signs or symptoms of acute or chronic paranasal sinus disease

          -  history of sinus surgery

          -  symptomatic deviated septum

          -  active seasonal allergies

          -  allergies to contrast

          -  history of nasal polyposis

          -  pregnant or breast feeding women

          -  neck or back problems that would prevent a subject from kneeling on the floor and
             crouching over

          -  currently taking metformin or amiodarone

          -  students or stff under the direct supervision of the investigators

          -  cognitive impairment

          -  terminal illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erin K O'Brien, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UNMC Department of Otolaryngology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Donald Leopold, MD</last_name>
    <role>Study Chair</role>
    <affiliation>UNMC Department of Otolaryngology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kelli L Olechoski, BA</last_name>
    <phone>402-689-0767</phone>
    <email>kolechos@unmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Erin K O'Brien, MD</last_name>
    <phone>402-559-7777</phone>
    <email>eobrien@unmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>ENT Specialist PC of Omaha</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kelli L Olechoski, BA</last_name>
      <phone>402-689-0767</phone>
      <email>kolechos@unmc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Senocak D, Senocak M, Bozan S. Sinonasal distribution of topically applied particles: computerized tomographic detection and the effects of topical decongestion. Otolaryngol Head Neck Surg. 2005 Dec;133(6):944-8.</citation>
    <PMID>16360518</PMID>
  </results_reference>
  <results_reference>
    <citation>Olson DE, Rasgon BM, Hilsinger RL Jr. Radiographic comparison of three methods for nasal saline irrigation. Laryngoscope. 2002 Aug;112(8 Pt 1):1394-8.</citation>
    <PMID>12172251</PMID>
  </results_reference>
  <results_reference>
    <citation>Wormald PJ, Cain T, Oates L, Hawke L, Wong I. A comparative study of three methods of nasal irrigation. Laryngoscope. 2004 Dec;114(12):2224-7.</citation>
    <PMID>15564850</PMID>
  </results_reference>
  <results_reference>
    <citation>Boatsman JE, Calhoun KH, Ryan MW. Relationship between rhinosinusitis symptoms and mucociliary clearance time. Otolaryngol Head Neck Surg. 2006 Mar;134(3):491-3.</citation>
    <PMID>16500451</PMID>
  </results_reference>
  <results_reference>
    <citation>Lund VJ, Black JH, Szab√≥ LZ, Schrewelius C, Akerlund A. Efficacy and tolerability of budesonide aqueous nasal spray in chronic rhinosinusitis patients. Rhinology. 2004 Jun;42(2):57-62.</citation>
    <PMID>15224630</PMID>
  </results_reference>
  <results_reference>
    <citation>Aukema AA, Fokkens WJ. Chronic rhinosinusitis: management for optimal outcomes. Treat Respir Med. 2004;3(2):97-105. Review.</citation>
    <PMID>15182211</PMID>
  </results_reference>
  <results_reference>
    <citation>Cannady SB, Batra PS, Citardi MJ, Lanza DC. Comparison of delivery of topical medications to the paranasal sinuses via &quot;vertex-to-floor&quot; position and atomizer spray after FESS. Otolaryngol Head Neck Surg. 2005 Nov;133(5):735-40.</citation>
    <PMID>16274802</PMID>
  </results_reference>
  <verification_date>February 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 20, 2008</study_first_submitted>
  <study_first_submitted_qc>February 20, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 29, 2008</study_first_posted>
  <last_update_submitted>February 20, 2008</last_update_submitted>
  <last_update_submitted_qc>February 20, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 29, 2008</last_update_posted>
  <responsible_party>
    <name_title>Erin O'Brien MD</name_title>
    <organization>University of Nebraska Medical Center</organization>
  </responsible_party>
  <keyword>Nasal Spray</keyword>
  <keyword>Nasal Drop</keyword>
  <keyword>Intranasal Medication</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sinusitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

